MetaCap

Optimi Health (OPTH) vs Zhengye Biotechnology (ZYBT)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.

Summary

Zhengye Biotechnology is the larger company by market cap ($54.5 million vs $23.4 million), about 2.3 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

OPTH-32.81%ZYBT+29.49%
+844%+384%-76%
May 20, 20261 yearOct 8, 2026
OPTH-30.17%ZYBT+32.32%
+143%+52%-38%
May 18, 20265 yearsOct 5, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

OPTH versus ZYBT key metrics
MetricOPTHZYBT
Share price$4.09$1.15
Market cap$23.39M$54.50M
1-day change0.00%-0.87%
YTD return—-0.01%
1-year return—-62.67%
EPS (TTM)$-1.56$-0.20
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
52-week high$6.40$8.01
52-week low$4.00$0.616
Distance from 52-week high-36.17%-85.64%
Average volume45.35K5.10M
Shares outstanding5.73M47.39M
Employees—269
SectorHealthcareHealthcare
IndustryDrug Manufacturers - Specialty & GenericDrug Manufacturers - Specialty & Generic

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • Zhengye Biotechnology is about 2.3 times larger than Optimi Health by market value ($54.50M vs $23.39M).

About Optimi Health

OPTH stock →

Optimi Health Corp. operates as a pharmaceutical and nutraceutical drug manufacturing company in Canada.

Healthcare · Drug Manufacturers - Specialty & Generic

About Zhengye Biotechnology

ZYBT stock →

Zhengye Biotechnology Holding Limited engages in the research, development, manufacture, and sale of veterinary vaccines for livestock in the People's Republic of China. The company offers vaccines for swine, cattle, goats, sheep, poultry, and dogs, as well as monovalent vaccine, polyvalent vaccine, combined vaccine, and combined and polyvalent vaccine.

Healthcare · Drug Manufacturers - Specialty & Generic · 269 employees

OPTH vs ZYBT FAQ

Which is bigger, Optimi Health or Zhengye Biotechnology?

Zhengye Biotechnology (ZYBT) is larger, with a market capitalization of $54.50M compared with $23.39M for Optimi Health (OPTH).

Are Optimi Health and Zhengye Biotechnology in the same industry?

Yes. Both are classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector.

More comparisons